InvestorsHub Logo
Followers 0
Posts 20
Boards Moderated 0
Alias Born 07/11/2003

Re: None

Friday, 08/22/2003 12:06:12 PM

Friday, August 22, 2003 12:06:12 PM

Post# of 82595
News could come from a variety of DNAP fronts:

I personally haven't heard a status update on products for quite a while, and would love to get a newsletter updating us on all of DNAP's products in the pipeline and where they are at. (at least the ones we know about.) Here's a little reminder of all the DNAP fronts we could get some news about:

1. DNAP receives Association of Crime Lab Directors (ASCLD) certification

2. AncestryByDNA version 3.0 released (last I heard was due by the end of this year. I think 3.0 will be tremendously more interesting than 2.0)

3. Hair color, eye color, and/or skin tone added to existing Forensic DNAWhitness product. (they are in process of getting 1000 more DNA samples, so not likely eye color will happen soon.)

4. News about existing ADMIXMAP collaborative research efforts. (I'll throw the NYU immunosuppressant project here, even though that collaborations were announced prior to ADMIXMAP platform product announcement.)

5. New ADMIXMAP collaborative research partnerships.

6. An update on Statinome. (Product supposedly due in 2003.) Is this in clinical trials? Perhaps FDA approval! FDA approval on Statinome will start the launch sequence on the PPS.

7. An update on Ovanome. (Conflicting reports of when this is due. At stockholder meeting, they said 2004. In 10Q they indicated "sooner than we think.")

8. news on acquiring a drug pipeline, becoming a pharmaceutical company.

9. New research grant award.

10. Confirmation and clarification of our relationship with DNA Phenomics. (Perhaps combination of #8, #9, and/or #10 at the same time.)

11. Lucrative partnership or contract for forensic work. (wouldn't an FBI contract be nice?)

12. News of another high profile criminal case solved with the help of DNAP.

13. A lucrative partnership with a company interested in bringing one of our pharmaceutical products to market.

14. A new project/product that none of us are aware of. (More than likely a pharmacogenetic project.)

I can think of some more sources of news, but not any that would be likely to effect the PPS, so I'll stop here.